As Chief Innovation Officer, Jill is responsible for driving innovation and integration across the enterprise. She works across the organization to identify, share, and scale the best ideas. Additionally, she is responsible for business transformation and strategy to research and explore new technologies, processes, and solutions for clients.
Jill is a seasoned leader in the Pharmaceutical Services sector where she most recently served as president of WCG’s Study Planning and Site Solutions. She also was vice president, Clinical Strategy at Veeva Systems and a variety of roles over 25 years with Covance including global vice president of Business Transformation. Jill began her career at Covance where she has personally been responsible for leading clinical study teams of pivotal Phase II and III clinical trials in the therapeutic areas of oncology, cardiovascular, metabolic and neurology.
Jill has been recognized for her contributions to the industry, receiving several awards for her leadership and achievements, including the Covance Excellence in Process award and the Chairman’s Award twice in her tenure. She holds several certifications, including Six Sigma Black Belt, Certified Project Management, and Certified Clinical Research Associate. She was also a founding member and Chapter President for the Association for Clinical Research Professionals (ACRP) in Philadelphia for several years.
Jill holds a BSc in Biology from SUNY – Environmental Science and Forestry and is an instructor for clinical monitoring at Mercer County College, supporting Drexel University’s Clinical Development Master program. She was previously the founding president of the ACRP Chapter in the Greater Philadelphia area and is a frequent speaker at industry conferences.